Young Richard A 4
4 · Syros Pharmaceuticals, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Young Richard A
Director
Transactions
- Sale
Common Stock
2024-06-28$5.12/sh−34,837$178,365→ 8,000 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 29, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.